Zuzanna Granek

7PUBLICATIONS
9CO-AUTHORS
Neurology and neuromuscular diseasesMedical infection agents (incl. prions)Toxicology (incl. clinical toxicology)Predictive and prognostic markersVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
Pharmacological Inhibition of JNK Signalling Exerts Anti-Neoplastic Effects on SH-SY5Y Human Neuroblastoma Cells.

Zuzanna Granek, Natalia Siwecka, Kamil Saramowicz

|Nov 09, 2024
Noradrenaline Protects Human Microglial Cells (HMC3) Against Apoptosis and DNA Damage Induced by LPS and Aβ1-42 Aggregates In Vitro.

Julia Barczuk, Grzegorz Galita, Natalia Siwecka

|Oct 16, 2024
Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer's Disease and Other Proteinopathies.

Szymon Kotarba, Marta Kozłowska, Małgorzata Scios

|Jul 27, 2024
IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells.

Natalia Siwecka, Grzegorz Galita, Zuzanna Granek

|Apr 27, 2024
NCI 159456 PERK Inhibitor as a Targeted Therapy for Lung Cancer: An In Vitro Study.

Wioletta Rozpędek-Kamińska, Grzegorz Galita, Natalia Siwecka

|Jan 23, 2024
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes.

Wioletta Rozpędek-Kamińska, Grzegorz Galita, Kamil Saramowicz

Pageof 2

Frequent Collaborators

7 joint publications

Natalia Siwecka

7 joint publications

Wioletta Rozpędek-Kamińska

6 joint publications

Grzegorz Galita

5 joint publications

Kamil Saramowicz